Red blood cell microparticles and blood group antigens: An analysis by flow cytometry

Blood Transfusion

Volumn 10, Issue SUPPL. 2, 2012, Pages

  Canellini, Giorgia ^a   Rubin, Olivier ^a   Delobel, Julien ^a   Crettaz, David ^a   Lion, Niels ^a   Tissot, Jean Daniel ^a  

^a Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

Author keywords

Blood group antigens; Erythrocytes; Microparticles

Indexed keywords

BLOOD GROUP ANTIGEN; CALCIUM IONOPHORE; GLYCOPHORIN A; GLYCOPHORIN B;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP LEWIS SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; BLOOD GROUP MNSS SYSTEM; BLOOD GROUP RH; CELL VACUOLE; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE MICROPARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE MICROPARTICLE; NORMAL HUMAN;

EID: 84861790902     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.007S     Document Type: Article

References (62)

1. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392-401. (Pubitemid 38859560)
2. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26. (Pubitemid 41811224)
3. van Beers EJ, Schaap MC, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513-9.
4. An X, Guo X, Sum H, et al. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry 2004; 43: 310-5. (Pubitemid 38082552)
5. Manno S, Takakuwa Y, Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci USA 2002; 99: 1943-8. (Pubitemid 34168994)
6. Bosman GJ, Werre JM, Willekens FL, Novotny VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-7.
7. Bosman GJ, Lasonder E, Luten M, et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008; 48: 827-35. (Pubitemid 351614907)
8. Arese P, Turrini F, Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005; 16: 133-46. (Pubitemid 41643014)
9. Kay M. Immunoregulation of cellular life span. Ann N Y Acad Sci 2005; 1057: 85-111. (Pubitemid 43211629)
10. Lang F, Gulbins E, Lerche H, et al. Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008; 22: 373-80.
11. Lion N, Crettaz D, Rubin O, Tissot JD. Stored red blood cells: a changing universe waiting for its map(s). J Proteomics 2010; 73: 374-85.
12. Minetti M, Malorni W. Redox control of red blood cell biology: the red blood cell as a target and source of prooxidant species. Antioxid Redox Signal 2006; 8: 1165-9. (Pubitemid 44182415)
13. Wagner GM, Chiu DT, Qju JH, et al. Spectrin oxidation correlates with membrane vesiculation in stored RBCs. Blood 1987; 69: 1777-81. (Pubitemid 17091640)
14. Gov NS, Safran SA. Red blood cell membrane fluctuations and shape controlled by ATP-induced cytoskeletal defects. Biophysical journal 2005; 88: 1859-74. (Pubitemid 40976199)
15. Sens P, Gov N. Force balance and membrane shedding at the red-blood-cell surface. Phys Rev Lett 2007; 98: 018102.
16. Gov N CJ, Sens P, Bosman GJCGM. Cytoskeletal Control of Red Blood Cell Shape: Theory and Practice of Vesicle Formation. In: Leitmannova Liu A, Iglic A, editors. Advances in Planar Lipid Bilayers and Liposomes. Burlington: Academic Press, Elsevier 2009; 10: 95-119.
17. Willekens FL, Werre JM, Groenen-Dopp YA, et al. Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol 2008; 141: 549-56. (Pubitemid 351550554)
18. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 2008; 48: 1943-53.
19. Rubin O, Crettaz D, Tissot JD, Lion N. Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta 2010; 82: 1-8.
20. Rubin O, Crettaz D, Canellini G, et al. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008; 95: 288-97.
21. Karon BS, Hoyer JD, Stubbs JR, Thomas DD. Changes in Band 3 oligomeric state precede cell membrane phospholipid loss during blood bank storage of red blood cells. Transfusion 2009; 49: 1435-42.
22. Salzer U, Zhu R, Luten M, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008; 48: 451-62. (Pubitemid 351294572)
23. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007; 104: 17063-8. (Pubitemid 350210992)
24. Gevi F, D'Alessandro A, Rinalducci S, Zolla L. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012; DOI 10.1016/j.jprot.2012.03.012
25. Ferru E, Giger K, Pantaleo A, et al. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood 2011; 117: 5998-6006.
26. Pantaleo A, Ferru E, Carta F, et al. Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells. PloS one 2011; 6: e15847.
27. Antonelou MH, Kriebardis AG, Stamoulis KE, et al. Red blood cell aging markers during storage in citrate-phosphate- dextrose-saline-adenine-glucose- mannitol. Transfusion 2010; 50: 376-89.
28. Bosman GJ, Lasonder E, Groenen-Dopp YA, et al. Comparative proteomics of erythrocyte aging in vivo and in vitro. J Proteomics 2010; 73: 396-402.
29. Karon BS, Van Buskirk CM, Jaben EA, et al. Temporal sequence of major biochemical events during Blood Bank storage of packed red blood cells. Blood Transfusion 2012; DOI 10.2450/2012.0099-11 .
30. D'Alessandro A, D'Amici GM, Vaglio S, Zolla L. Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica 2012; 97: 107-15.
31. Chaudhary R, Katharia R. Oxidative injury as contributory factor for red cells storage lesion during twenty eight days of storage. Blood Transfusion 2012; 10: 59-62.
32. Sadallah S, Eken C, Schifferli JA. Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol 2008; 84: 1316-25.
33. Greenwalt TJ. The how and why of exocytic vesicles. Transfusion 2006; 46: 143-52. (Pubitemid 43381798)
34. Helias V, Saison C, Ballif BA, et al. ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis. Nature genetics 2012; 44: 170-3.
35. Daniels G, Reid ME. Blood groups: the past 50 years. Transfusion 2010; 50: 281-9.
36. Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol 2004; 41: 93-117. (Pubitemid 38509637)
37. Anstee DJ. The functional importance of blood group-active molecules in human red blood cells. Vox Sang 2011; 100: 140-9.
38. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood 2008; 112: 3939-48.
39. Pantaleo A, De Franceschi L, Ferru E, et al. Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. J Proteomics 2010; 73: 445-55.
40. Michel FW. The Occurrence of Blood-Group Specific Material in the Plasma and Serum of Stored Blood. Vox Sang 1964; 9: 471-5.
41. Cole WF, Rumsby MG, Longster GH, Tovey LA. Changes in the inhibition of specific agglutination by plasma due to microvesicles released from human red cells during storage for transfusion. Vox Sang 1979; 37: 73-7. (Pubitemid 10225835)
42. Xiong Z, Cavaretta J, Qu L, et al. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011; 51: 610-21.
43. Oreskovic RT, Dumaswala UJ, Greenwalt TJ. Expression of blood group antigens on red cell microvesicles. Transfusion 1992; 32: 848-9. (Pubitemid 23001633)
44. Victoria EJ, Branks MJ, Masouredis SP. Immunoreactivity of the Rho(D) antigen in cytoskeleton-free vesicles. Transfusion 1987; 27: 32-5. (Pubitemid 17030031)
45. Zimring JC, Hair GA, Chadwick TE, et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005; 106: 1105-12. (Pubitemid 41076461)
46. Powers A, Mohammed M, Uhl L, Haspel RL. Apparent nonhemolytic alloantibody-induced red-cell antigen loss from transfused erythrocytes. Blood 2007; 109: 4590. (Pubitemid 46743434)
47. Head DJ, Lee ZE, Swallah MM, Avent ND. Ligation of CD47 mediates phosphatidylserine expression on erythrocytes and a concomitant loss of viability in vitro. Br J Haematol 2005; 130: 788-90. (Pubitemid 43906652)
48. Kumpel B. Are weak D RBCs really immunogenic? Transfusion 2006; 46: 1061-2. (Pubitemid 43800930)
49. Kitazawa J, Nollet K, Morioka H, et al. Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles? Vox Sang 2011; 100: 395-400.
50. Bosman GJ. Erythrocyte aging in sickle cell disease. Cell Mol Biol (Noisy-le-grand) 2004; 50: 81-6.
51. Westerman M, Pizzey A, Hirschman J, et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 2008; 142: 126-35. (Pubitemid 351783151)
52. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76: 1431-7. (Pubitemid 20342762)
53. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988; 148: 2485-9.
54. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617-21. (Pubitemid 20171584)
55. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41: 1086-92. (Pubitemid 32848083)
56. Godfrey GJ, Lockwood W, Kong M, et al. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis. Pediatr Blood Cancer 2010; 55: 1134-7.
57. de Isla NG, Riquelme BD, Rasia RJ, et al. Quantification of glycophorin A and glycophorin B on normal human RBCs by flow cytometry. Transfusion 2003; 43: 1145-52. (Pubitemid 37022377)
58. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 2006; 21: 167-74.
59. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39. (Pubitemid 351439224)
60. Lee JS, Gladwin MT. Bad blood: the risks of red cell storage. Nat Med 2010; 16: 381-2.
61. Veale MF, Healey G, Sparrow RL. Effect of additive solutions on red blood cell (RBC) membrane properties of stored RBCs prepared from whole blood held for 24 hours at room temperature. Transfusion 2011; 51 (Suppl. 1): S25-33.
62. Kim-Shapiro DB, Lee J, Gladwin MT. Storage lesion: role of red blood cell breakdown. Transfusion 2011; 51: 844-51.